Zevra Therapeutics, Inc. (ZVRA) Operating income 2016–2025
Zevra Therapeutics, Inc. (ZVRA) annual operating income history from SEC filings — each fiscal year as reported.
-$62.9MFY2025 · since FY2016: -$37.5M → -$62.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.9M | +27.7% |
| FY2024 | -$87.0M | -75.4% |
| FY2023 | -$49.6M | -16.5% |
| FY2022 | -$42.6M | -650.7% |
| FY2021 | $7.7M | +237.8% |
| FY2020 | -$5.6M | +72.4% |
| FY2019 | -$20.3M | +63.6% |
| FY2018 | -$55.9M | -67.5% |
| FY2017 | -$33.4M | +11.0% |
| FY2016 | -$37.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice